Indraprastha Medical Corporation Limited Stock Price Today (NSE: INDRAMEDCO)
Fundamental Score
Indraprastha Medical Corporation Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Indraprastha Medical Corporation Limited share price today is ₹320.05, down 0.44% on NSE/BSE as of 16 October 2026. Indraprastha Medical Corporation Limited (INDRAMEDCO) is a Small-cap company in the Hospital sector with a market capitalisation of ₹2.93K (Cr). The 52-week high for INDRAMEDCO share price is ₹640.85 and the 52-week low is ₹317.05. At a P/E ratio of 15.60x, INDRAMEDCO is currently trading below its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 27.47% and a debt-to-equity ratio of 0.00.
Indraprastha Medical Corporation Limited Share Price Chart — NSE/BSE Historical Performance
Indraprastha Medical Corporation Limited share price chart: -10.24% return over the past month. 52-week high ₹640.85, 52-week low ₹317.05.
Indraprastha Medical Corporation Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹321.00 | ₹323.00 | ₹317.05 | ₹320.05 | 84.09K (Cr) | |
| ₹327.80 | ₹329.00 | ₹320.00 | ₹321.45 | 1.03L (Cr) | |
| ₹331.00 | ₹331.70 | ₹326.30 | ₹327.80 | 78.92K (Cr) | |
| ₹327.25 | ₹333.00 | ₹323.45 | ₹329.95 | 5.25L (Cr) | |
| ₹329.00 | ₹333.00 | ₹325.35 | ₹331.20 | 59.26K (Cr) | |
| ₹320.00 | ₹331.80 | ₹319.90 | ₹329.05 | 1.45L (Cr) | |
| ₹329.40 | ₹332.25 | ₹317.15 | ₹319.90 | 5.91L (Cr) | |
| ₹335.15 | ₹336.60 | ₹327.75 | ₹329.40 | 1.58L (Cr) | |
| ₹334.00 | ₹336.55 | ₹327.35 | ₹335.15 | 2.10L (Cr) | |
| ₹341.85 | ₹342.25 | ₹331.55 | ₹333.95 | 1.19L (Cr) |
Indraprastha Medical Corporation Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹345.00 | ₹346.25 | ₹317.05 | ₹320.05 | -7.23% | |
| ₹363.00 | ₹379.95 | ₹340.20 | ₹348.95 | -3.87% | |
| ₹367.00 | ₹405.90 | ₹360.80 | ₹363.05 | -1.08% | |
| ₹388.05 | ₹393.40 | ₹358.25 | ₹366.35 | -5.59% | |
| ₹380.45 | ₹411.00 | ₹368.60 | ₹388.05 | +2.00% | |
| ₹409.65 | ₹441.00 | ₹351.20 | ₹380.35 | -7.15% | |
| ₹381.60 | ₹444.00 | ₹381.60 | ₹402.05 | +5.36% | |
| ₹382.40 | ₹414.40 | ₹365.00 | ₹372.35 | -2.63% | |
| ₹376.00 | ₹439.00 | ₹355.30 | ₹402.05 | +6.93% | |
| ₹451.00 | ₹460.45 | ₹342.00 | ₹363.15 | -19.48% | |
| ₹516.50 | ₹516.50 | ₹438.10 | ₹448.10 | -13.24% | |
| ₹603.00 | ₹640.85 | ₹503.80 | ₹512.50 | -15.01% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Indraprastha Medical Corporation Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Indraprastha Medical Corporation Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of INDRAMEDCO across key market metrics for learning purposes.
Positive Indicators
13 factors identified
Strong Return on Equity (27.47%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (33.72%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (16.19%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 15.60 vs Industry: 48.79)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (19.30% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (140.30% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (139.52% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (41.87x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 2.46)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Strong Cash Generation (₹523.68 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (51.00%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Limited Institutional Interest (FII+DII: 3.23%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Indraprastha Medical Corporation Limited vs Hospital Peers
Peer Comparison - Hospital
Compare Indraprastha Medical Corporation Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Indraprastha Medical Corporation LimitedIndraprastha Me...Selected✓ INDRAMEDCO • 532150 | 68.3/100 | ₹320.05₹320 | ₹2933.90₹2933.90 | 15.60Average 15.6 Average | 27.47%Excellent 27.47% Excellent | 33.72%Excellent 33.72% Excellent | 0.00Excellent 0.0 Excellent | 139.52%Excellent 139.52% Excellent | 19.30%Excellent 19.30% Excellent | 1.19% |
Apollo Hospitals Enterprise LimitedApollo Hospital... APOLLOHOSP • 508869 | 64.1/100 | ₹7890.00₹7890 | ₹113458.20₹113458.20 | 54.29Average 54.3 Average | 21.95%Excellent 21.95% Excellent | 19.28%Good 19.28% Good | 0.60Good 0.6 Good | 66.81%Excellent 66.81% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LimitedMax Healthcare ... MAXHEALTH • 543220 | 55.5/100 | ₹846.00₹846 | ₹82336.10₹82336.10 | 56.44Average 56.4 Average | 14.33%Average 14.33% Average | 13.43%Average 13.43% Average | 0.32Excellent 0.3 Excellent | 60.01%Excellent 60.01% Excellent | 27.30%Excellent 27.30% Excellent | 0.18% |
Fortis Healthcare LimitedFortis Healthca... FORTIS • 532843 | 50.6/100 | ₹736.50₹737 | ₹55602.80₹55602.80 | 53.06Average 53.1 Average | 11.08%Average 11.08% Average | 12.83%Average 12.83% Average | 0.29Excellent 0.3 Excellent | 64.38%Excellent 64.38% Excellent | 17.76%Excellent 17.76% Excellent | 0.10% |
Narayana Hrudayalaya Ltd.Narayana Hruday... NH • 539551 | 65.7/100 | ₹1719.40₹1719 | ₹35137.83₹35137.83 | 42.79Average 42.8 Average | 19.74%Good 19.74% Good | 14.53%Average 14.53% Average | 1.07Average 1.1 Average | 155.30%Excellent 155.30% Excellent | 25.05%Excellent 25.05% Excellent | 0.22% |
Aster DM Quality Care LimitedAster DM Qualit... ASTERDM • 540975 | 49.5/100 | ₹674.35₹674 | ₹34940.10₹34940.10 | 109.12Average 109.1 Average | 9.70%Poor 9.70% Poor | 11.35%Average 11.35% Average | 0.15Excellent 0.2 Excellent | 21.31%Excellent 21.31% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Global Health LimitedGlobal Health L... MEDANTA • 543654 | 57.9/100 | ₹1240.00₹1240 | ₹33327.48₹33327.48 | 59.90Average 59.9 Average | 15.15%Good 15.15% Good | 16.85%Good 16.85% Good | 0.30Excellent 0.3 Excellent | 80.71%Excellent 80.71% Excellent | 24.97%Excellent 24.97% Excellent | 0.04% |
27.7/100 | ₹685.60₹686 | ₹28795.20₹28795.20 | 134.43Average 134.4 Average | 11.01%Average 11.01% Average | 9.35%Poor 9.35% Poor | 1.44Average 1.4 Average | 3.71%Average 3.71% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Dr. Agarwal's Health Care LimitedDr. Agarwal's H... AGARWALEYE • 544350 | 57.3/100 | ₹465.80₹466 | ₹14765.86₹14765.86 | 99.32Average 99.3 Average | 6.84%Poor 6.84% Poor | 10.16%Average 10.16% Average | 0.08Excellent 0.1 Excellent | 34.42%Excellent 34.42% Excellent | 34.58%Excellent 34.58% Excellent | 0.00% |
Rainbow Childrens Medicare LimitedRainbow Childre... RAINBOW • 543524 | 73/100 | ₹1248.90₹1249 | ₹12684.58₹12684.58 | 44.43Average 44.4 Average | 17.86%Good 17.86% Good | 18.10%Good 18.10% Good | 0.00Excellent 0.0 Excellent | 44.04%Excellent 44.04% Excellent | 21.24%Excellent 21.24% Excellent | 0.23% |
Yatharth Hospital & Trauma Care Services LimitedYatharth Hospit... YATHARTH • 543950 | 66.1/100 | ₹992.10₹992 | ₹9559.28₹9559.28 | 52.77Average 52.8 Average | 9.98%Poor 9.98% Poor | 12.29%Average 12.29% Average | 0.14Excellent 0.1 Excellent | 57.39%Excellent 57.39% Excellent | 41.18%Excellent 41.18% Excellent | 0.00% |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Limited share price113458.20 Cr
- Max Healthcare Institute Limited share price82336.10 Cr
- Fortis Healthcare Limited share price55602.80 Cr
- Narayana Hrudayalaya Ltd. share price35137.83 Cr
- Aster DM Quality Care Limited share price34940.10 Cr
Indraprastha Medical Corporation Limited PE Ratio History
Historical price-to-earnings ratio for INDRAMEDCO — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹17.56 | ₹448.10 | 25.5x |
| FY 2024 | ₹13.52 | ₹522.90 | 38.7x |
| FY 2023 | ₹9.40 | ₹172.45 | 18.3x |
| FY 2022 | ₹6.39 | ₹83.10 | 13x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Indraprastha Medical Corporation Limited Dividend History
Annual cash dividends paid by INDRAMEDCO — dividend yield 1.19%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹40.73 Cr |
| FY 2024 | ₹27.54 Cr |
| FY 2023 | ₹22.84 Cr |
| FY 2022 | ₹0.26 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Indraprastha Medical Corporation Limited Quarterly Performance
Latest quarterly metrics for INDRAMEDCO — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
11.26%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
8.53%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
19.30%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
139.52%
Compounded annual net profit growth over 5 years
Indraprastha Medical Corporation Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for INDRAMEDCO — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Indraprastha Medical Corporation Limited Financial Statements
Annual income statement, balance sheet and cash flow for Indraprastha Medical Corporation Limited (INDRAMEDCO) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Indraprastha Medical Corporation Limited
About INDRAMEDCO (Indraprastha Medical Corporation Limited)
Indraprastha Medical Corporation Ltd is a beacon of advanced healthcare nestled in the heart of India, a sprawling complex dedicated to healing and wellness. The hospital's archite...cture blends seamlessly with verdant landscaping, offering patients and visitors a tranquil environment conducive to recovery. Inside, a network of brightly lit corridors connects state-of-the-art diagnostic centers with comfortable, private patient rooms. The air hums with quiet efficiency, a testament to the dedicated team of medical professionals working tirelessly. The aroma of freshly prepared meals wafts from the dietary services, while the gentle murmur of conversations creates a sense of community, reassuring patients that they are not alone on their journey to restored health. INDRAMEDCO distinguishes itself through its unwavering commitment to cutting-edge technology and specialized medical expertise. It houses a vast array of specialized units, each staffed with highly skilled physicians, nurses, and technicians. From the precision of robotic surgery suites to the advanced imaging capabilities of the radiology department, every resource is geared towards providing accurate diagnoses and effective treatments. The hospital boasts specialized clinics dedicated to addressing a wide spectrum of medical needs, ranging from intricate cardiovascular procedures to delicate neurological interventions. Its commitment to research and innovation drives it to continuously refine its treatment protocols, ensuring patients receive the best care. Beyond its impressive medical capabilities, INDRAMEDCO fosters a patient-centric culture rooted in compassion and empathy. The staff is trained to not only address the physical ailments of patients but also to provide emotional support and understanding. Warm smiles and attentive listening are integral parts of the healing process, creating a sense of trust and connection. INDRAMEDCO also emphasizes preventative care, with programs designed to promote healthy lifestyles and reduce the risk of chronic diseases. This holistic approach to healthcare, combined with its commitment to medical excellence, makes INDRAMEDCO a trusted name in healthcare.
Company Details
Key Leadership
INDRAMEDCO Share Price: Frequently Asked Questions
What is the current share price of Indraprastha Medical Corporation Limited?
Indraprastha Medical Corporation Limited (INDRAMEDCO) trades at ₹320.05 on NSE and BSE. Market cap ₹2.93K (Cr). Educational data only.
What is the P/E ratio of Indraprastha Medical Corporation Limited?
Indraprastha Medical Corporation Limited has a P/E of 15.60x vs industry average 48.79x.
What is the Bull Run score for Indraprastha Medical Corporation Limited?
Indraprastha Medical Corporation Limited has a Bull Run score of 68.3/100 based on 25+ financial parameters.
Does Indraprastha Medical Corporation Limited pay dividends?
Indraprastha Medical Corporation Limited has a dividend yield of 1.19%. Past dividends don't guarantee future payments.
What is the ROE of Indraprastha Medical Corporation Limited?
Indraprastha Medical Corporation Limited has ROE of 27.47%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Indraprastha Medical Corporation Limited?
Indraprastha Medical Corporation Limited has debt-to-equity of 0.00.
Is Indraprastha Medical Corporation Limited a good investment?
Bull Run gives Indraprastha Medical Corporation Limited a score of 68.3/100. This is not investment advice — consult a SEBI-registered advisor.